STOCKHOLM – Elekta (EKTA-B.ST) announces the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio. This strategic move bolsters Elekta’s position in treatment planning and underscores its commitment to being the innovation leader in radiation therapy.Elekta and Philips have reached an agreement to transfer Philips’ patent portfolio in the radiation oncology treatment planning domain to Elekta, unlocking further innovations in radiation therapy treatment planning and workflow optimization. By integrating the technologies covered by the acquired patent portfolio, Elekta and Philips aim to offer a seamless and best-in-class transition for existing Pinnacle users to Elekta ONE Planning, including data conversion services, showcased at the upcoming ESTRO event.In June 2021, Elekta and Philips announced their long-term strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions, from CT and MR simulation to treatment planning, preparation and delivery.Maurits Wolleswinkel, President, Linac and Software Solutions at Elekta, said: “Thanks to continued investments over the years, our treatment planning system supports both Elekta and non-Elekta devices, including proton therapy, making Elekta ONE Planning one of the most competitive solutions in the market. At ESTRO, we will unveil exciting new capabilities, including novel scripting elements inspired by Pinnacle, demonstrating Elekta ONE’s competitive advantage.”Martijn Hartjes, Business Leader Clinical Informatics at Philips, added: “We are pleased that we can continue to support our customers with leading solutions in radiation oncology. This is a logical next step in the strong long-term collaboration between Philips and Elekta in the radiotherapy domain to improve cancer care together.”See a live demo of Elekta ONE, and how it will elegantly include Pinnacle-related technology, at ESTRO 2024, May 3-7 in Glasgow, UK at Elekta’s booth #440.# # #For further information, please contact:Mattias Thorsson, Vice President, Head of Corporate CommunicationsTel: +46 70 865 8012, e-mail: [email protected] zone: CET: Central European TimeRaven Canzeri, Global Director, Media RelationsTel: +1 770-670-2524, e-mail: [email protected] zone: ET: Eastern TimeAbout ElektaAs a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer

GE Healthcare subsidiary MIM Software will expand a partnership with Elekta to develop radiation therapy software.

What You Should Know:– Just weeks after acquiring MIM Software, a leader in medical imaging analysis and AI solutions, GE HealthCare strengthens its commitment to improving cancer care through a deeper collaboration with Elekta, a leader in precision radiation oncology.– The strategic partnership aims to revolutionize radiation therapy workflows and ultimately benefit both patients and healthcare providers.Addressing Challenges in Radiation TherapyNearly two-thirds of all cancer patients undergo radiation therapy, but current processes can be time-consuming due to a lack of interoperability and automation. This can significantly impact patient outcomes. The collaboration specifically addresses these challenges by leveraging AI-powered software and advanced imaging capabilities.The collaboration will focus on developing innovative software solutions designed to:Improve Workflow Efficiency: Streamline workflows within radiation therapy treatment planning, enhancing efficiency for clinicians.Streamline workflows within radiation therapy treatment planning, enhancing efficiency for clinicians. Increase Throughput: Reduce the time it takes for patients to receive radiation treatment, minimizing delays.Reduce the time it takes for patients to receive radiation treatment, minimizing delays. Enhance User Experience: Make the treatment planning process more user-friendly for clinicians.GE HealthCare’s MIM Software and Elekta’s treatment planning software will be combined to create a powerful solution for oncology treatment planning. This collaboration builds upon both companies’ existing strengths in regional markets, ensuring the solutions can be adopted globally.“Our decision to join GE HealthCare was driven by a ‘shared vision of maximizing impact’ and our motivation for this collaboration with Elekta is no different,” explains Andy Nelson, CEO of MIM Software, GE HealthCare